A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433
Clinical trial NCT03345823 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03345823
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-21
- Primary completion
- 2027-09-01
- Enrollment
- 747
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.